Valuation (93%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.64 | N/A |
| PEG Ratio (TTM) | 0.41 | N/A |
| P/S Ratio (TTM) | 0.37 | N/A |
| P/B Ratio (TTM) | 2.61 | N/A |
| P/FCF Ratio (TTM) | 18.66 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.31 | N/A |
| Price to 5YR AVG FCF Ratio | 6.24 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.15% | N/A |
| ROE (TTM) | 13.85% | N/A |
| Net Profit Margin (TTM) | 1.91% | N/A |
| ROIC 5YR AVG | 22.35% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.11% | 625.28% | 328.92% |
| Revenue | 2.29% | 22.88% | 11.06% |
| Net Income | 0.40% | 642.80% | 339.13% |
| Cash Flow | 186.30% | 23.45% | 6.50% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.51 | N/A |
| Quick Ratio (TTM) | 3.49 | N/A |
| D/E Ratio (TTM) | 2.02 | N/A |
| Interest Coverage (TTM) | 2.61 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 3.51 | N/A |
| LTL to 5YR AVG FCF | 5.83 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.62% | N/A |